CN104491744A - Traditional Chinese medicine composition for treating myelofibrosis caused by qi stagnation and blood stasis - Google Patents

Traditional Chinese medicine composition for treating myelofibrosis caused by qi stagnation and blood stasis Download PDF

Info

Publication number
CN104491744A
CN104491744A CN201510002500.3A CN201510002500A CN104491744A CN 104491744 A CN104491744 A CN 104491744A CN 201510002500 A CN201510002500 A CN 201510002500A CN 104491744 A CN104491744 A CN 104491744A
Authority
CN
China
Prior art keywords
parts
radix
blood stasis
stagnation
grams
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510002500.3A
Other languages
Chinese (zh)
Inventor
杨茹芹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510002500.3A priority Critical patent/CN104491744A/en
Publication of CN104491744A publication Critical patent/CN104491744A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/24Mucus; Mucous glands; Bursa; Synovial fluid; Arthral fluid; Excreta; Spinal fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/62Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11Pteridophyta or Filicophyta (ferns)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/47Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/57Magnoliaceae (Magnolia family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/67Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition for treating myelofibrosis caused by qi stagnation and blood stasis. The composition is characterized by being prepared from the following medicinal materials in parts by weight: 6-9 parts of curcuma zedoary, 12-15 parts of bauhinia seeds, 9-12 parts of undulata hand.-mazz, 15-18 parts of Chinese astilbe rhizome, 12-15 parts of kadsura coccinea, 6-9 parts of leeches, 15-20 parts of cantonese speranskia, 6-9 parts of vanieria thorn, 3-6 parts of fructus polygoni orientalis, 5-8 parts of trogopterus dung, 6-9 parts of Chinese ivy fruits, 1-3 parts of Piper sarmentosum Roxb, 3-6 parts of goldhair grmnopteris herb rhizome, 10-15 parts of Chinese ixora flower roots, 1-3 parts of citrus aurantium, 15-20 parts of ciliate leucas, 5-10 parts of semen aesculi and 5-7 parts of liquorice. The traditional Chinese medicine composition disclosed by the invention for treating myelofibrosis caused by qi stagnation and blood stasis is high in effective rate and reliable in curative effect, and myelofibrosis cured does not relapse.

Description

A kind of Chinese medicine composition for the treatment of qi stagnation and blood stasis type myelofibrosis
Technical field
The present invention relates to a kind of Chinese medicine, particularly a kind of Chinese medicine composition being used for the treatment of qi stagnation and blood stasis type myelofibrosis.
Background technology
Myelofibrosis belongs to " asthenia blood deficiency ", " gathering " category of the traditional Chinese medical science.Cause the reason of myelofibrosis mainly contain following some: 1., depressed rage impairing the liver, functional activity of QI being not smooth, qi depression to blood stasis, with the passing of time injures Liver and kidney, no resource of generating and transforming QI and blood, and the deficiency of YIN is raw interior-heat then.2., ponder over the easy impairment of the spleen, dysfunction of the spleen in transportation, retention of water-damp in the body, extremity lose supports, or kidney-yang deficiency, and blood deficiency can not go up flourish women's head-ornaments.3., spleen is source of generating QI and blood, and the biochemical weary source of insufficiency of the spleen then QI and blood, cause QI and blood deficiency, the heart is become homeless foster, or insufficiency of the spleen transporting mistake department.Qi as the commander of blood, blood being the mother of qi, and with the passing of time the deficiency of vital energy, then causes qi depression to blood stasis, stops in blood stasis, and venation is obstructed, and long-pending in bulk, causes pain due to blood stasis for a long time.4., internal injury caused by excess of seven emotions, cause depression of liver-QI, catharsis mistake department, functional activity of QI being not smooth, the stagnation of QI is blood stasis then, stagnation of blood stasis, for a long time long-pending in bulk, and venation is obstructed, stagnation of QI and blood may bring about pain; Or liver-QI transversely invading the stomach, stomach-QI being unable to descend normally.Primary disease main manifestations is that skin mucosa is pale, purpura, the fatigue and weak engendered, becomes thin weak, and hepatosplenomegaly, Progressive symmetric erythrokeratodermia anemia, some patients has bone joint pain, renal colic, heating, left epigastric discomfort, heavy constriction or pain.At present, the myelofibrosis cause of disease, pathogenesis are not clear, and doctor trained in Western medicine lacks effectively treatment.Mainly with suiting the medicine to the illness, transfusing blood the treatments such as support, androgen, chemotherapy, interferon, partial row splenectomy, these treatment general curative effects are poor, and toxic and side effects is large, fundamentally can not cure this disease.Chinese medicine both can improve clinical symptoms, again by replenishing QI and blood, invigorating the liver and kidney, improved hematopoieticmicroenviron-ment, promoted the recovery of hemopoietic function, fundamentally cured this disease.The different times of the myelofibrosis that the traditional Chinese medical science causes according to different reason and progression of disease, carries out Coryza Treated by Syndrome Differentiation in conjunction with clinical practice, is divided into by primary disease: liver-kidney yin deficiency, yang deficiency of spleen and stomache, QI and blood deficiency folder stasis of blood type, qi stagnation and blood stasis type.At present, the Chinese medicine for the treatment of myelofibrosis has multiple, but the Chinese patent medicine being directed to qi stagnation and blood stasis type myelofibrosis there is no report.
Summary of the invention
Object of the present invention aims to provide a kind of Chinese medicine composition for the treatment of qi stagnation and blood stasis type myelofibrosis, by selecting suitable medical material and proportioning thereof, reaches the object of safe and effective healing qi stagnation and blood stasis type myelofibrosis.
For achieving the above object, the present invention by the following technical solutions: a kind of Chinese medicine composition for the treatment of qi stagnation and blood stasis type myelofibrosis, is characterized in that being made up of the medical material of following weight proportion:
Rhizoma Curcumae 6-9 part, Semen Bauhiniae championii 12-15 part, Radix Araliae undulatae 9-12 part, Radix astilbes chinensis (Rhizoma Astilbes Chinensis) 15-18 part, Caulis Kadsurae Coccineae 12-15 part, Hirudo 6-9 part, Herba speranskiae cantonensis 15-20 part, Spina Cudraniae Cochinchinensis 6-9 part, Fructus Polygoni Orientalis 3-6 part, Oletum Trogopterori 5-8 part, the sub-1-3 part of Fructus hederae sinensis 6-9 part, Radix Piperis sarmentosi (Herba Piperis Sarmentosi), Radix seu Herba Gymnopteris vestitae 3-6 part, Radix Ixorae Chinensis 10-15 part, Citrus aurantium L. var. amara Engl. 1-3 part, Herba leucadis ciliatae 15-20 part, Semen Aesculi 5-10 part, Radix Glycyrrhizae 5-7 part.
Source and the function of medical material involved in formula cure mainly as follows:
Rhizoma Curcumae [source] medical material Ji Yuan: be the rhizome of zingiberaceous plant Rhizoma Curcumae, Guangxi zedoary and RADIX CURCUMAE.[nature and flavor] acrid in the mouth; Bitter; [return through] warm in nature returns liver, spleen channel [function cures mainly] circulation of qi promoting removing blood stasis; Removing food stagnancy pain relieving.Main vim and vigour are pained; Eating accumulation; Abdominal distention; Amenorrhea due to stagnation of blood; Dysmenorrhea; Lump in the abdomen tumor mass in the abdomen; Traumatic injury.
Semen Bauhiniae championii [source] medical material Ji Yuan: be the seed of leguminous plant Caulis Bauhihiae Championii.[nature and flavor] toil; Temperature [return through] liver; Stomach is through [function cures mainly] promoting the circulation of QI to relieve pain; Blood circulation promoting and blood stasis dispelling.Main distending pain over the hypochondrium, gastric abscess, traumatic injury.
Radix Araliae undulatae [source] medical material Ji Yuan: be the root of Araliaceae Radix Araliae undulatae.[nature and flavor] bitter in the mouth; Pungent; [function cures mainly] cool in nature blood circulation promoting and blood stasis dispelling; Inducing menstruation to relieve menalgia; Expelling wind and removing dampness.Main traumatic injury; Fracture; Mass in the abdomen; Amenorrhea; Dysmenorrhea; Impairment caused by overstrain pain; Rheumatalgia.
The rhizome that Radix astilbes chinensis (Rhizoma Astilbes Chinensis) [source] is saxifragaceae plant Herba astilbes chinensis etc.Summer, autumn adopt, removing fibrous root, scale, fine hair, using fresh herb or dry.[nature and flavor] are warm in nature, puckery.[function cures mainly] blood circulation promoting and blood stasis dispelling, pain relieving, removing toxic substances.Control traumatic injury, joint bones and muscles pain, stomachache, postoperative pain.
Caulis Kadsurae Coccineae [source] medical material Ji Yuan: be root and the viticula of Schisandraceae Plant Kadsura coccinea (Lem.) A.C. Smith.[nature and flavor] are pungent; Micro-hardship; Warm in nature.[function cures mainly] promoting the circulation of QI to relieve pain; Dissipating blood stasis dredging collateral.Cure mainly gastric and duodenal ulcers; Chronic gastritis; Acute gastroenteritis; Rheumatic arthralgia; Traumatic injury; Fracture; Dysmenorrhea; Postnatal blood stasis is suffered from abdominal pain; Colicky.
Hirudo [source] this product is the dry body of Hirudinidae animal whitmania Whitmania pigra Whitman, Hirudo Hirudo nipponica Whitman or Folium Salicis Babylonicae Hirudo Whit-mania acranulata Whitman.[nature and flavor] are salty, bitter, flat; Slightly poisonous.[return through] returns Liver Channel.[function cures mainly] removing blood stasis, removing blood stasis, stimulates the menstrual flow.For lump in the abdomen mass in the abdomen, blood stasis amenorrhea, injury from falling down.
Herba speranskiae cantonensis [source] medical material Ji Yuan: be the herb of euphorbia plant Guangdong speranskia tuberculata.[nature and flavor] are bitter; Flat [return through] lung; Liver; Large intestine channel [function cures mainly] wind-damp dispelling; The meridian dredging; Removing blood stasis with potent drugs pain relieving.Main air pain of dampness syndrome; Lump in the abdomen; Scrofula; Furuncle swelling toxin; Traumatic injury.
Spina Cudraniae Cochinchinensis [source] medical material Ji Yuan: be moraceae plants cudrania cochinchinensis Spina jujubae.[nature and flavor] are bitter; Slightly warm in nature [function cures mainly] blood stasis dispelling removing food stagnancy.Gather in main abdomen; Mass in the abdomen.
Fructus Polygoni Orientalis [source] medical material Ji Yuan: be the fruit of the thin knotweed of polygonaceae plant.[nature and flavor] are salty; [return through] cool in nature liver; Spleen channel [function cures mainly] promoting blood circulation to remove stagnancy; Invigorating spleen to remove dampness; Heat-clearing and toxic substances removing; Improving eyesight.Main flank disease is amassed; Dropsy; Gastric abscess; Lack of appetite abdominal distention; Acute catarrhal conjunctivitis; Skin ulcer swells; Scrofula.
Oletum Trogopterori [source] medical material Ji Yuan: be the dry feces of flying squirrel section animal trogopterus xanthipes Milne-Edwards.[nature and flavor] bitter in the mouth; Sweet; [return through] warm in nature liver; Spleen channel [function cures mainly] promoting blood circulation and stopping pain; Removing stasis to stop bleeding; Removing food stagnancy detoxifies.The all pains of main trusted subordinate's vim and vigour; Women's amenorrhea; The stagnant stomachache of the stasis of blood in puerperal; Metrostaxis; Infantile malnutrition; Snakes and scorpions centipete bite.
Fructus hederae sinensis [source] medical material Ji Yuan: be the fruit of Araliaceae Caulis Hederae Sinensis.[nature and flavor] sweet in the mouth; Bitter; [function cures mainly] warm in nature invigorating the liver and kidney; Strong waist knee joint, promoting the circulation of QI to relieve pain.Main body void is frail; Soreness of the waist and knees, arthralgia due to stagnation of blood; Coldness and pain in the epigastrium.
Radix Piperis sarmentosi (Herba Piperis Sarmentosi) [source] medical material Ji Yuan: be the fruit ear of Piperaceae plant Radix Piperis sarmentosi (Herba Piperis Sarmentosi) PipersarmentosumRoxb..[nature and flavor] are pungent; Temperature [function cures mainly] warming spleen and stomach for dispelling cold; Promoting the circulation of QI to relieve pain; Removing dampness is subsided a swelling.Main abdominal distention; Cold-damp is suffered from diarrhoea; Rheumatic arthralgia; Colicky; Toothache; Edema.
Radix seu Herba Gymnopteris vestitae [source] medical material Ji Yuan: be herb or the rhizome of Hemionitidaceae plant gold hair psilophyton.[nature and flavor] are pungent; Bitter; Cool [return through] lung; Stomach is through [function cures mainly] heat-clearing and toxic substances removing; Promoting the circulation of QI to relieve pain.The high heat of main typhoid fever; Arthralgia; Stomachache.
Radix Ixorae Chinensis [source] medical material Ji Yuan: be the root of dicotyledon medicine Maguireothamnus speciosus Flos Ixorae Chinensis (Cacumen et Folium Clerodendri paniculati).[nature and flavor] are bitter; Micro-puckery; Cool [return through] lung; Stomach is through [function cures mainly] clearing away heat and cooling blood; Promoting blood circulation and stopping pain.Main cough; Spitting of blood; Rheumatic arthritis; Stomachache; Women's amenorrhea; Skin infection swells and ache; Traumatic injury.
Citrus aurantium L. var. amara Engl. [source] medical material Ji Yuan: be the alabastrum of rutaceae Citrus aurantium L. var. amara Engl..[nature and flavor] are pungent; Sweet; Micro-hardship; Property flat [function cures mainly] to regulate the flow of vital energy the chest stuffiness relieving; Stomach function regulating preventing or arresting vomiting.It is main that painful abdominal mass is vexed in the heart; Abdominal distention; Anorexia; Nausea and vomiting.
Herba leucadis ciliatae [source] medical material Ji Yuan: be the herb of labiate Herba leucadis ciliatae.[nature and flavor] bitter in the mouth; Pungent; Property flat [function cures mainly] dispersing liver and promoting blood circulation; By wind improving eyesight; Removing toxic substances.Housewife female's blood stasis amenorrhea; The pain over the hypochondriac region; Night blindness in children; Optic atrohic blindness cataracta; Swollen ulcer drug; Syphilis of the bone; Scabies; Erythra.
Semen Aesculi [source] medical material Ji Yuan: be the fruits and seeds of Hippocastanaceae plant Aesculus chinensis Bunge, Radix Aesculi or Aesculus.[nature and flavor] sweet in the mouth; [return through] warm in nature liver; Stomach is soothing the liver through [function cures mainly]; Regulate the flow of vital energy; Alleviating distention in middle-JIAO; Pain relieving.The main breast side of body; Distending pain of the breast; Dysmenorrhea; Gastric abscess.
Radix Glycyrrhizae [source] this product is the dry root of glycyrrhizic legume Glycyrrhiza uralensis Fisch., Glycyrrhiza inflata Bat. Glycyrrhiza inflata Bat. or Glycyrrhiza glabra L. Glycyrrhiza glabra L..[nature and flavor] are sweet, flat.[return through] GUIXIN, lung, spleen, stomach warp.[function cures mainly] invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.For weakness of the spleen and stomach, fatigue and weakness, shortness of breath and palpitation, cough with copious phlegm, the anxious pain of gastral cavity abdomen, extremity contraction, carbuncle sore tumefacting virus, cushion toxicity, strong.
In the process of tcm syndrome differentiation and treatment, we are usually in conjunction with auxiliary facilities, then do Skeletal X-ray or histopathological inspection, lab testing, bone marrow radioisotope scan inspection further, determine the course of disease of patient further, can be divided into for three phases by the order of severity:
Early stage complete blood cell hyperplasia accompanied is slight the myelofibrosis phase: medullary cell is the hypertrophy of degree varies.Red, all hypertrophy such as grain, megakaryocytic series are the most obvious with megalokaryocyte.Fat vacuole disappears, and reticular fiber increases, but does not still affect the normal configuration of bone marrow.Hematopoietic cell accounts for more than 70%.Bone marrow matrix increases to master with soluble collagen.
Mid-term bone marrow suppression and fibrosis phase: proliferation of fibrous tissue is given prominence to, and account for the 40%-60% of bone marrow, hematopoietic cell accounts for 30%, and megalokaryocyte is hypertrophy still.Bone trabecula increases, it is thick to increase, and has new bone formation with bone marrow adjacent regions.Each is dispersed in parallel pencil that hemopoietic region formed by reticular fiber, collagen fiber, plasma cell and stromal cell or helical form material is separated.
Late period myelofibrosis and osteosclerosis phase: myelofibrosis whole latter stage.Based on the bone trabecula hypertrophy of sclerotin, account for the 30-40% of bone marrow.All significantly hypertrophy is organized in fiber and osteosclerosis, and pulp cavity is narrow, and except megalokaryocyte still can be regarded sb. as an outsider, other hematopoietic cells significantly reduce.In this phase bone marrow matrix composition, polymeric protein is main, main manifestations fibronectin, and outer connection albumen distribution increases.
The clinical manifestation of qi stagnation and blood stasis type myelofibrosis is distension and fullness in the abdomen, has block under rib, soft and not hard, does not fixingly move, or pain, pain in fixed position, and there is ecchymosis on the dark red or tongue limit of tongue, and tongue is white, stringy and tense pulse or puckery.Therapeutic Principle is blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain.The present invention adopts formula and the proportioning of science, and the Rhizoma Curcumae adopted in formula has effect of circulation of qi promoting removing blood stasis, removing food stagnancy pain relieving; Semen Bauhiniae championii has effect of promoting the circulation of QI to relieve pain, blood circulation promoting and blood stasis dispelling; Radix Araliae undulatae has effect of blood circulation promoting and blood stasis dispelling, inducing menstruation to relieve menalgia, expelling wind and removing dampness; Radix astilbes chinensis (Rhizoma Astilbes Chinensis) has effect of blood circulation promoting and blood stasis dispelling, pain relieving, removing toxic substances; Caulis Kadsurae Coccineae has effect of promoting the circulation of QI to relieve pain, dissipating blood stasis dredging collateral; Hirudo has removing blood stasis, removing blood stasis, the effect of stimulating the menstrual flow; Herba speranskiae cantonensis has effect of wind-damp dispelling, the meridian dredging, removing blood stasis with potent drugs pain relieving; Spina Cudraniae Cochinchinensis has effect of blood stasis dispelling removing food stagnancy; Fructus Polygoni Orientalis has effect of promoting blood circulation to remove stagnancy, invigorating spleen to remove dampness, heat-clearing and toxic substances removing, improving eyesight; Oletum Trogopterori has effect of promoting blood circulation and stopping pain, removing stasis to stop bleeding, removing food stagnancy removing toxic substances; Fructus hederae sinensis has effect of invigorating the liver and kidney, strong waist knee joint, promoting the circulation of QI to relieve pain; Radix Piperis sarmentosi (Herba Piperis Sarmentosi) has effect of warming spleen and stomach for dispelling cold, promoting the circulation of QI to relieve pain, removing dampness detumescence; Radix seu Herba Gymnopteris vestitae has effect of heat-clearing and toxic substances removing, promoting the circulation of QI to relieve pain; Radix Ixorae Chinensis has effect of clearing away heat and cooling blood, promoting blood circulation and stopping pain; Citrus aurantium L. var. amara Engl. has effect of the chest stuffiness relieving of regulating the flow of vital energy, stomach function regulating preventing or arresting vomiting; Herba leucadis ciliatae has dispersing liver and promoting blood circulation, by effect of wind improving eyesight, removing toxic substances; Semen Aesculi have soothing the liver, regulate the flow of vital energy, alleviating distention in middle-JIAO, pain relieving effect; Radix Glycyrrhizae has effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.Cooperatively interact between each medicine in formula, synergism, made Chinese medicine has effect of blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain, can effectively treat qi stagnation and blood stasis type myelofibrosis, over 4 years, by showing the use of 80 routine patients, effective percentage reaches 96.2%, therapeutic effect is good, follows up a case by regular visits to and no longer recur for 1 year after healing.
Below in conjunction with clinical laboratory data, beneficial effect of the present invention is described:
1, sampling approach
Be diagnosed as the patient of qi stagnation and blood stasis type myelofibrosis from my unit over nearly 5 years, the routine patient of random selecting 160, wherein, man 80 example, female 80 example, age 38-78 year, be divided into matched group and treatment group at random, often organize each 80 people.The data there was no significant differences such as two groups of ages, have comparability.
2, test method
2.1 matched group patients use Busulfan, and by specification is taken, 10 weeks courses for the treatment of.
The oral the present invention of 2.2 treatment group according to the obtained Chinese medicinal granule of specific embodiment 1, early, middle and late each once.10 weeks courses for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterions of therapeutical effect:
Clinical recovery: clinical asymptomatic, spleen reduces and reaches under rib within 2 cm, hemocyte quantity in normal range, without inmature grain, erythroneocytosis; Myelosis degree is normal; Bone marrow biopsy hypertrophy fiber absorbs; More than 1 year without recurrence.Effective: clinical asymptomatic, spleen reduces and reaches 1/2 or more; Hemocyte quantity in normal range, without inmature grain, erythroneocytosis; Myelosis degree is normal; Bone marrow biopsy hypertrophy pars fibrosa absorbs.Effective: clinical symptoms has clear improvement; Spleen reduces before comparatively treating, but does not reach 1/2; At least one item of blood cell count reaches normal range, and inmature grain, erythroneocytosis comparatively treat front minimizing 1/2 or more.Invalid: the person that do not reach at criterion of progress.
3.2 treatment statistical results are in table 1.
Table 1 liang group comparitive study
As can be seen here, the medicine adopting prescription of the present invention obtained can safe and effective treatment qi stagnation and blood stasis type myelofibrosis.
Detailed description of the invention
Below in conjunction with the concrete example implemented, further detailed description is done to the present invention.
Embodiment 1
Take Rhizoma Curcumae 9 grams, Semen Bauhiniae championii 15 grams, Radix Araliae undulatae 12 grams, Radix astilbes chinensis (Rhizoma Astilbes Chinensis) 18 grams, Caulis Kadsurae Coccineae 15 grams, Hirudo 9 grams, Herba speranskiae cantonensis 20 grams, Spina Cudraniae Cochinchinensis 9 grams, Fructus Polygoni Orientalis 6 grams, Oletum Trogopterori 8 grams, Fructus hederae sinensis 9 grams of, Radix Piperis sarmentosi (Herba Piperis Sarmentosi) 3 grams, Radix seu Herba Gymnopteris vestitae 6 grams, Radix Ixorae Chinensis 15 grams, Citrus aurantium L. var. amara Engl. 3 grams, Herba leucadis ciliatae 20 grams, Semen Aesculi 10 grams, 7 grams, Radix Glycyrrhizae.Various medical material grinding is become end, then uses conventional method " whole part " to extract and make instant Chinese medicine granule, carry out subpackage according to every pouch 10 grams, airtight, preserve in shady and cool, dry place.
Be used for the treatment of qi stagnation and blood stasis type myelofibrosis.Oral, every bu is taken for early, middle and late three times.
Specific embodiment 2
Take Rhizoma Curcumae 6 grams, Semen Bauhiniae championii 12 grams, Radix Araliae undulatae 9 grams, Radix astilbes chinensis (Rhizoma Astilbes Chinensis) 15 grams, Caulis Kadsurae Coccineae 12 grams, Hirudo 6 grams, Herba speranskiae cantonensis 15 grams, Spina Cudraniae Cochinchinensis 6 grams, Fructus Polygoni Orientalis 3 grams, Oletum Trogopterori 5 grams, Fructus hederae sinensis 6 grams of, Radix Piperis sarmentosi (Herba Piperis Sarmentosi) 1 gram, Radix seu Herba Gymnopteris vestitae 3 grams, Radix Ixorae Chinensis 10 grams, Citrus aurantium L. var. amara Engl. 1 gram, Herba leucadis ciliatae 15 grams, Semen Aesculi 5 grams, 5 grams, Radix Glycyrrhizae.Various medical material grinding is become end, then uses conventional method " whole part " to extract and make instant Chinese medicine granule, carry out subpackage according to every pouch 10 grams, airtight, preserve in shady and cool, dry place.
Be used for the treatment of qi stagnation and blood stasis type myelofibrosis.Oral, every bu is taken for early, middle and late three times.
Specific embodiment 3
Take Rhizoma Curcumae 8 grams, Semen Bauhiniae championii 13 grams, Radix Araliae undulatae 10 grams, Radix astilbes chinensis (Rhizoma Astilbes Chinensis) 17 grams, Caulis Kadsurae Coccineae 13 grams, Hirudo 8 grams, Herba speranskiae cantonensis 16 grams, Spina Cudraniae Cochinchinensis 8 grams, Fructus Polygoni Orientalis 5 grams, Oletum Trogopterori 7 grams, Fructus hederae sinensis 8 grams of, Radix Piperis sarmentosi (Herba Piperis Sarmentosi) 2 grams, Radix seu Herba Gymnopteris vestitae 5 grams, Radix Ixorae Chinensis 11 grams, Citrus aurantium L. var. amara Engl. 2 grams, Herba leucadis ciliatae 16 grams, Semen Aesculi 8 grams, 6 grams, Radix Glycyrrhizae.Various medical material grinding is become end, then uses conventional method " whole part " to extract and make instant Chinese medicine granule, carry out subpackage according to every pouch 10 grams, airtight, preserve in shady and cool, dry place.
Be used for the treatment of qi stagnation and blood stasis type myelofibrosis.Oral, every bu is taken for early, middle and late three times.

Claims (1)

1. treat a Chinese medicine composition for qi stagnation and blood stasis type myelofibrosis, it is characterized in that being made up of the medical material of following weight proportion:
Rhizoma Curcumae 6-9 part, Semen Bauhiniae championii 12-15 part, Radix Araliae undulatae 9-12 part, Radix astilbes chinensis (Rhizoma Astilbes Chinensis) 15-18 part, Caulis Kadsurae Coccineae 12-15 part, Hirudo 6-9 part, Herba speranskiae cantonensis 15-20 part, Spina Cudraniae Cochinchinensis 6-9 part, Fructus Polygoni Orientalis 3-6 part, Oletum Trogopterori 5-8 part, the sub-1-3 part of Fructus hederae sinensis 6-9 part, Radix Piperis sarmentosi (Herba Piperis Sarmentosi), Radix seu Herba Gymnopteris vestitae 3-6 part, Radix Ixorae Chinensis 10-15 part, Citrus aurantium L. var. amara Engl. 1-3 part, Herba leucadis ciliatae 15-20 part, Semen Aesculi 5-10 part, Radix Glycyrrhizae 5-7 part.
CN201510002500.3A 2015-01-05 2015-01-05 Traditional Chinese medicine composition for treating myelofibrosis caused by qi stagnation and blood stasis Pending CN104491744A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510002500.3A CN104491744A (en) 2015-01-05 2015-01-05 Traditional Chinese medicine composition for treating myelofibrosis caused by qi stagnation and blood stasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510002500.3A CN104491744A (en) 2015-01-05 2015-01-05 Traditional Chinese medicine composition for treating myelofibrosis caused by qi stagnation and blood stasis

Publications (1)

Publication Number Publication Date
CN104491744A true CN104491744A (en) 2015-04-08

Family

ID=52933258

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510002500.3A Pending CN104491744A (en) 2015-01-05 2015-01-05 Traditional Chinese medicine composition for treating myelofibrosis caused by qi stagnation and blood stasis

Country Status (1)

Country Link
CN (1) CN104491744A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105560634A (en) * 2015-09-09 2016-05-11 李传仁 Traditional Chinese medicine for treating amyotrophic lateral sclerosis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
陈泊等: "《中西医结合血液病治疗学》", 31 January 2001, 人民军医出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105560634A (en) * 2015-09-09 2016-05-11 李传仁 Traditional Chinese medicine for treating amyotrophic lateral sclerosis

Similar Documents

Publication Publication Date Title
CN103536748B (en) The Chinese medicine for the treatment of pathogenic fire derived from stagnation of liver-QI pattern of syndrome goiter
CN103520573B (en) Traditional Chinese medicine for treating liver depression and blood stasis syndrome type breast nodule diseases
CN104587282A (en) Traditional Chinese medicine composition for treating liver and kidney deficiency type cervical spondylosis
CN104689179A (en) Traditional Chinese medicine composition for treatment of acute attack of gouty arthritis
CN104758524A (en) Traditional Chinese medicinal composition for treating hepatic hemangioma with symptoms of phlegm dampness and retention
CN104888019A (en) Traditional Chinese medicine composition for treatment of stomach-Yin deficiency type chronic gastritis
CN103520352B (en) The Chinese medicine for the treatment of stasis blocking venation pattern of syndrome obstruction of qi in the chest and cardialgia
CN104491744A (en) Traditional Chinese medicine composition for treating myelofibrosis caused by qi stagnation and blood stasis
CN104758488A (en) Traditional Chinese medicine composition for treating hepatic hemangioma caused by qi stagnation and blood stasis
CN101912502A (en) Traditional Chinese medicine for treating acute urethrocystitis
CN104771585A (en) Traditional Chinese medicine composition for treating acute nephritis and preparation method thereof
CN104887950A (en) Mastitis treatment traditional Chinese medicine compound
CN105147884A (en) Traditional Chinese medicinal composition for treating cervical spondylotic radiculopathy with syndrome of deficiency of qi and blood
CN104524277A (en) Traditional Chinese medicine mixture for treating anorexia nervosa
CN104740332A (en) Traditional Chinese medicine used for treating erythema nodosum
CN103536892B (en) Traditional Chinese medicine for treating infertility of syndrome of yang deficiency and coagulated cold
CN103656199B (en) A kind of Chinese medicine for the treatment of deficiency of kidney yin syndrome cough
CN101129751A (en) Traditional Chinese medicine composition for treating anormogenesis of mamma masculina
CN105362554A (en) Traditional Chinese medicine for treating poliomyelitis due to liver-kidney deficiency
CN104288365A (en) Traditional Chinese medicine for treating amenorrhea due to qi stagnation and blood stasis
CN104971240A (en) Traditional Chinese medicinal composition for treating liver fire invading stomach type chronic gastritis
CN104208305A (en) Traditional Chinese medicine for treating abdominal mass caused by qi stagnation and blood stasis
CN106511808A (en) Traditional Chinese medicine composition for treating cold-dampness pyretic arthralgia type rheumatic fever
CN105902809A (en) Traditional Chinese medicinal composition for treating blood stasis productive cough induced acute leukemia, and preparation method thereof
CN104758774A (en) Traditional Chinese medicine composition for treating accumulation with syndrome of internal binding of blood stasis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150408

WD01 Invention patent application deemed withdrawn after publication